Why don't we have a pan-tumor drug that targets BRCA mutations?

<p>The challenges of targeting BRCA mutations in all cancers</p><p><br></p><p>Tumor lineage shapes BRCA-mediated phenotypes: https://pmc.ncbi.nlm.nih.gov/articles/PMC7048239/</p>